Results for

""Antibodies, Monoclonal, Murine-Derived""[mesh_terms]

Maintenance therapy for B-chronic lymphocytic leukemia.

Neil E Kay, Susan O'Brien

Clinical advances in hematology & oncology : H&O 2011;9(1):22-31

Recent Advances in Autoimmune Pancreatitis.

Phil A Hart, Yoh Zen, Suresh T Chari

Gastroenterology 2015;149(1):39-51

Dermatomyositis and polymyositis: new treatment targets on the horizon.

A E Hak, B de Paepe, J L de Bleecker, P-P Tak, M de Visser

The Netherlands journal of medicine 2012;69(10):410-21

Repeated radioimmunotherapy with 131I-rituximab for patients with low-grade and aggressive relapsed or refractory B cell non-Hodgkin lymphoma.

Hye Jin Kang, Seung-Sook Lee, Byung Hyun Byun, Kyeong Min Kim, Ilhan Lim, Chang Woon Choi, Cheolwon Suh, Won Seog Kim, Seung-Hyun Nam, Soon Il Lee, Hyeon Seok Eom, Dong-Yeop Shin, Sang Moo Lim

Cancer chemotherapy and pharmacology 2013;71(4):945-53

Efficacy and safety of tositumomab and iodine-131 tositumomab (Bexxar) in B-cell lymphoma, progressive after rituximab.

Sandra J Horning, Anas Younes, Vinay Jain, Stewart Kroll, Jennifer Lucas, Donald Podoloff, Michael Goris

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(4):712-9

A phase III trial of CHOP vs CHOP + rituximab vs CHOP + 1-131 tositumomab for newly diagnosed follicular non-Hodgkin lymphoma.

Clinical advances in hematology & oncology : H&O 2007;4(7):536-8

Targeted radioimmunotherapy for leptomeningeal cancer using (131)I-3F8.

K Kramer, N K Cheung, J L Humm, E Dantis, R Finn, S J Yeh, N L Antunes, I J Dunkel, M Souwedaine, S M Larson

Medical and pediatric oncology 2001;35(6):716-8

B7H3-Directed Intraperitoneal Radioimmunotherapy With Radioiodinated Omburtamab for Desmoplastic Small Round Cell Tumor and Other Peritoneal Tumors: Results of a Phase I Study.

Shakeel Modak, Pat Zanzonico, Milan Grkovski, Emily K Slotkin, Jorge A Carrasquillo, Serge K Lyashchenko, Jason S Lewis, Irene Y Cheung, Todd Heaton, Michael P LaQuaglia, Nai-Kong V Cheung, Neeta Pandit-Taskar

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2021;38(36):4283-4291

Cholesterol depletion inhibits src family kinase-dependent calcium mobilization and apoptosis induced by rituximab crosslinking.

Tammy L Unruh, Haidong Li, Cathlin M Mutch, Neda Shariat, Lana Grigoriou, Ratna Sanyal, Christopher B Brown, Julie P Deans

Immunology 2005;116(2):223-32

Radioimmunotherapy combined with maintenance anti-CD20 antibody may trigger long-term protective T cell immunity in follicular lymphoma patients.

Franz Buchegger, Steven M Larson, Jean-Pierre Mach, Yves Chalandon, Pierre-Yves Dietrich, Anne Cairoli, John O Prior, Pedro Romero, Daniel E Speiser

Clinical & developmental immunology 2014;2013():875343

Identification of CD20 C-terminal deletion mutations associated with loss of CD20 expression in non-Hodgkin's lymphoma.

Yasuhito Terui, Yuji Mishima, Natsuhiko Sugimura, Kiyotsugu Kojima, Takuma Sakurai, Yuko Mishima, Ryoko Kuniyoshi, Akiko Taniyama, Masahiro Yokoyama, Sakura Sakajiri, Kengo Takeuchi, Chie Watanabe, Shunji Takahashi, Yoshinori Ito, Kiyohiko Hatake

Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(7):2523-30

Immunotherapy in mantle cell lymphoma: anti-CD20-based therapy and beyond.

Yuhong Zhou, Liang Zhang, Jorge Romaguera, Kay Delasalle, Xiaohong Han, Xin Du, Larry Kwak, Qing Yi, Michael Wang

American journal of hematology 2008;83(2):144-9

Adjuvant therapy of colon cancer.

Daniel G Haller, Weijing Sun

Seminars in oncology 2005;32(1):95-102

Sorafenib improves rituximab and ofatumumab efficacy by decreasing the expression of complement regulatory proteins.

M Dwojak, M Bobrowicz, J Bil, K Bojarczuk, B Pyrzynska, M Siernicka, A Malenda, E Lech-Maranda, W Tomczak, K Giannopoulos, J Golab, M Winiarska

Blood cancer journal 2015;5(4):e300

Rituximab plus gemcitabine: a therapeutic option for elderly or frail patients with aggressive non Hodgkin's lymphoma?

R Herrmann, M Stern, M Pless, C Wenger, Ch Rochlitz

Leukemia & lymphoma 2005;46(1):71-5